Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
about
Alpha2-adrenergic agonists for the management of opioid withdrawalAlpha2-adrenergic agonists for the management of opioid withdrawalAlpha 2 -adrenergic agonists for the management of opioid withdrawalAffective and neuroendocrine effects of withdrawal from chronic, long-acting opiate administration.Effects of sleep deprivation on sleep homeostasis and restoration during methadone-maintenance: a [31]P MRS brain imaging studyEvidence-based addiction medicine: the use of lofexidine for opioid detoxification.Electroacupuncture treatment normalized sleep disturbance in morphine withdrawal rats.Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapseResponse inhibition and psychomotor speed during methadone maintenance: impact of treatment duration, dose, and sleep deprivation.Antagonist-precipitated and discontinuation-induced withdrawal in morphine-dependent rhesus monkeys.Self administration of heroin and cocaine in morphine-dependent and morphine-withdrawn rhesus monkeys.Opiate-induced changes in brain adenosine levels and narcotic drug responses.Addiction: the clinical interface.The AC/AG Diplotype for the 118A>G and IVS2 + 691G>C Polymorphisms of OPRM1 Gene is Associated with Sleep Quality Among Opioid-Dependent Patients on Methadone Maintenance TherapyPrevalence of restless legs syndrome during detoxification from alcohol and opioids.Suppressive effects of rosa damascena essential oil on naloxone- precipitated morphine withdrawal signs in male miceA study on Fu-Yuan Pellet, a traditional chinese medicine formula for detoxification of heroin addictions.Combined buprenorphine and chlonidine for short-term opiate detoxification: patient perspectives.Lofexidine for opiate detoxification.Opioid antagonists with minimal sedation for opioid withdrawalPredictors of sleep disturbance in heroin users receiving methadone maintenance therapy: a naturalistic study in Taiwan
P2860
Q24185795-E53A767D-ED04-48F5-B292-9943B0006979Q24197769-53895974-006E-496A-8E00-25D919F6E901Q24241305-2D31DB6A-08D0-46DA-9EB9-6B887DCDC957Q30426271-022021C7-A2DA-4DAA-9ECD-C225712EFB13Q33932225-9AABF086-031F-422F-B927-5F10CC7FA48DQ34444149-4AAAC867-228A-4463-857F-370B8C5D8586Q35108027-7B542A3A-B937-422E-B1C0-6D75AECB0823Q36024183-C3B168F5-960F-4C2A-8F3A-AEC7B6F85623Q36164768-62AFCD4C-81E2-45E7-AF84-86E9741A868EQ36254257-C9C2888B-7FAC-4789-AFCB-3D0BE7986E21Q36286905-492CCEFB-B947-4873-A1C0-D451F3FCB855Q36476253-FA7B5E8B-C2B9-42AE-AFF4-C4D684C7F5E7Q36741908-1E01121E-9044-41C1-91B6-1D92392CA734Q37018618-BD49FCE1-2B2E-48B9-881A-179BA454798BQ39066046-F3FBBE1D-4DB6-430A-A5AA-74283EDFD5EBQ42078366-9D951581-4B5A-4C49-B800-0C4626A3167CQ43218775-68C3DE51-11D9-417F-A16B-EB1DDCA49533Q48505880-4B96E52A-74FE-4EC3-9061-673B8BE0C16AQ52309012-67776840-0DDC-4460-A701-C4AB8A8FAA5FQ56289303-24437E8E-19AF-4C3A-BAE6-B723F9ED02BDQ59126218-075038EF-FC95-4DFF-8D7D-3A3E78F18E13
P2860
Major disruptions of sleep during treatment of the opiate withdrawal syndrome: differences between methadone and lofexidine detoxification treatments.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Major disruptions of sleep dur ...... ine detoxification treatments.
@en
Major disruptions of sleep dur ...... ine detoxification treatments.
@nl
type
label
Major disruptions of sleep dur ...... ine detoxification treatments.
@en
Major disruptions of sleep dur ...... ine detoxification treatments.
@nl
prefLabel
Major disruptions of sleep dur ...... ine detoxification treatments.
@en
Major disruptions of sleep dur ...... ine detoxification treatments.
@nl
P2093
P2860
P1433
P1476
Major disruptions of sleep dur ...... dine detoxification treatments
@en
P2093
Jenny Bearn
Michael Gossop
Tracy Beswick
P2860
P356
10.1080/1355621031000069882
P577
2003-03-01T00:00:00Z